GKOS
Glaukos Corporation · Healthcare · Medical - Devices
The first ingest from SEC EDGAR is still running — this section fills in automatically as filings are parsed. Nothing here is placeholder data: when a number appears, it comes from a real filing.
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passive) | 2.06M | — | $309.39M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 1.21M | -2.5% | $182.08M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 1.20M | +2.1% | $179.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 1.20M | +2.1% | $179.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.19M | +231.8% | $178.84M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.19M | +231.8% | $178.84M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 563.49K | +5.9% | $84.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Capital World Investors ✦ | 550.32K | 0.0% | $82.52M | 0.0% | Held | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 393.22K | +62.3% | $58.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 280.31K | -26.9% | $42.03M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 49.60K | +30.6% | $7.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 35.18K | +13.7% | $5.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 23.40K | -86.5% | $3.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 7.59K | +16.2% | $1.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 7.59K | +16.2% | $1.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 7.59K | +16.2% | $1.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 5.82K | -30.5% | $872,651 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 5.21K | -1.2% | $781,037 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.70K | +73.1% | $404,988 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $16.78M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 333 holders, 57.55M shares, $6.09B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 2.50K sh · $475,000
Officer · 27.96K sh · $5.00M
Officer · 32.04K sh · $5.78M
Officer · 20.00K sh · $3.60M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology